ArticleHaemophilia : the official journal of the World Federation of Hemophilia
Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research.
Article in Haemophilia : the official journal of the World Federation of Hemophilia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Swiss Haemophilia Registry-Report From the First 8 Years.Haemophilia : the official journal of the World Federation of HemophiliaObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo enhance the treatment quality in haemophilia centres (HC), the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research (GTH) started in 2017 the development of guidelines to define the structural and process quality of HC, essentially related to the EUHANET guidelines.
aimA certification process for HC located in Germany, Austria and Switzerland started in 2019.
methodsWithin the first 5 years, 17 Haemophilia Comprehensive Care Centres (HCCC; ≥ 40 patients with severe HaemA/HaemB or vWD Type 3) and 6 Haemophilia Treatment Centres (HTC; ≥ 10 patients) were certified following a 1-day on-site audit performed by two trained haemophilia doctors. Experienced quality management staff supported the audit preparation in the HC. The entire certification process was coordinated by the accredited certification body ClarCert.
resultsIn the vast majority of the HCs, the precise specifications of the GTH guidelines in combination with the intensive audit preparation resulted in a mean number of only 2.80 nonconformities per audit (range 0-14). In addition, a mean number of 5.96 (range 2-13) recommendations were documented by the auditors. The feedback of the centres showed a high level of satisfaction with an excellent rating for both the professional auditors and ClarCert as the organizing certification body.
conclusionAfter the successful implementation of the certification process, a certificate is now an essential prerequisite for HC in Germany to conclude separate contracts regarding comprehensive care with health insurance bodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.